miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3
MicroRNA plays an important role in gastric cancer (GC) development, while the function of miR-497-5p in this disease remains unknown. In the present study, we demonstrated miR-497-5p as a tumor suppressive microRNA in GC. miR-497-5p was down-regulated in GC tissues and its expression was associated...
Saved in:
Published in | Bioscience reports Vol. 39; no. 9 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Portland Press Ltd
30.09.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | MicroRNA plays an important role in gastric cancer (GC) development, while the function of miR-497-5p in this disease remains unknown. In the present study, we demonstrated miR-497-5p as a tumor suppressive microRNA in GC. miR-497-5p was down-regulated in GC tissues and its expression was associated with the disease stage. Inhibition of miR-497-5p promoted GC cell proliferation and growth. By contrast, miR-497-5p ectopic expression suppressed the proliferation and growth of GC cells. In addition, miR-497-5p inhibited DNA synthesis and enhanced apoptosis in GC cells. The cell cycle progression was suppressed by miR-497-5p. Mechanistically, miR-497-5p directly targeted and suppressed the expression of pyruvate dehydrogenase kinase 3 (PDK3), which is highly expressed in GC tissues. Over-expression of PDK3 promoted the proliferation of GC cells. Our study revealed that miR-497-5p inhibited GC cell proliferation and growth via targeting PDK3. |
---|---|
AbstractList | MicroRNA plays an important role in gastric cancer (GC) development, while the function of miR-497-5p in this disease remains unknown. In the present study, we demonstrated miR-497-5p as a tumor suppressive microRNA in GC. miR-497-5p was down-regulated in GC tissues and its expression was associated with the disease stage. Inhibition of miR-497-5p promoted GC cell proliferation and growth. By contrast, miR-497-5p ectopic expression suppressed the proliferation and growth of GC cells. In addition, miR-497-5p inhibited DNA synthesis and enhanced apoptosis in GC cells. The cell cycle progression was suppressed by miR-497-5p. Mechanistically, miR-497-5p directly targeted and suppressed the expression of pyruvate dehydrogenase kinase 3 (PDK3), which is highly expressed in GC tissues. Over-expression of PDK3 promoted the proliferation of GC cells. Our study revealed that miR-497-5p inhibited GC cell proliferation and growth via targeting PDK3. MicroRNA plays an important role in gastric cancer (GC) development, while the function of miR-497-5p in this disease remains unknown. In the present study, we demonstrated miR-497-5p as a tumor suppressive microRNA in GC. miR-497-5p was down-regulated in GC tissues and its expression was associated with the disease stage. Inhibition of miR-497-5p promoted GC cell proliferation and growth. By contrast, miR-497-5p ectopic expression suppressed the proliferation and growth of GC cells. In addition, miR-497-5p inhibited DNA synthesis and enhanced apoptosis in GC cells. The cell cycle progression was suppressed by miR-497-5p. Mechanistically, miR-497-5p directly targeted and suppressed the expression of pyruvate dehydrogenase kinase 3 (PDK3), which is highly expressed in GC tissues. Over-expression of PDK3 promoted the proliferation of GC cells. Our study revealed that miR-497-5p inhibited GC cell proliferation and growth via targeting PDK3.MicroRNA plays an important role in gastric cancer (GC) development, while the function of miR-497-5p in this disease remains unknown. In the present study, we demonstrated miR-497-5p as a tumor suppressive microRNA in GC. miR-497-5p was down-regulated in GC tissues and its expression was associated with the disease stage. Inhibition of miR-497-5p promoted GC cell proliferation and growth. By contrast, miR-497-5p ectopic expression suppressed the proliferation and growth of GC cells. In addition, miR-497-5p inhibited DNA synthesis and enhanced apoptosis in GC cells. The cell cycle progression was suppressed by miR-497-5p. Mechanistically, miR-497-5p directly targeted and suppressed the expression of pyruvate dehydrogenase kinase 3 (PDK3), which is highly expressed in GC tissues. Over-expression of PDK3 promoted the proliferation of GC cells. Our study revealed that miR-497-5p inhibited GC cell proliferation and growth via targeting PDK3. |
Author | Zang, Rongjia Feng, Lan Wang, Qingdong Wang, Jianjie Cheng, Kai |
Author_xml | – sequence: 1 givenname: Lan surname: Feng fullname: Feng, Lan organization: Department of Infection Medicine, First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang Province, People’s Republic of China – sequence: 2 givenname: Kai surname: Cheng fullname: Cheng, Kai organization: Department of Infection Medicine, First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang Province, People’s Republic of China – sequence: 3 givenname: Rongjia surname: Zang fullname: Zang, Rongjia organization: Department of Infection Medicine, First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang Province, People’s Republic of China – sequence: 4 givenname: Qingdong surname: Wang fullname: Wang, Qingdong organization: Department of Infection Medicine, First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang Province, People’s Republic of China – sequence: 5 givenname: Jianjie orcidid: 0000-0003-0074-9073 surname: Wang fullname: Wang, Jianjie organization: Department of Immunology, Basic Medical College, Jiamusi University, Jiamusi, Heilongjiang Province, People’s Republic of China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31409724$$D View this record in MEDLINE/PubMed |
BookMark | eNptkctLJDEQxoO46Pg4eZccBendvLv7Iuioq6yg-MBjyCTpnkhPMiYZZf_7zfjCFU91qF9931dVG2DVB28B2MHoJ0aM_Dq6uSYIt0hwtgJGmNe0Yi3lq2CEMGNVwwRdBxspPSCESoOtgXWKGWprwkbgfuauC15XfA6dn7qJywn2KuXoNNTKaxuhtsMA5zEMrrNRZRc8VN7APobnPIV5GsOiL1XF3mbne3h1_IdugR-dGpLdfqub4O705HZ8Vl1c_j4fH15UmrE6Vwa1xpBGUMOpnShseNvxklM0THPDOqYFazQypLPLzKhrMLGC08bWZoIIp5vg4FV3vpjMrNHW56gGOY9upuJfGZST_3e8m8o-PElRU0LFUmDvTSCGx4VNWc5cWm6svA2LJAkpIBIlUUF3P3t9mLxfswD4FdAxpBRtJ7XLLwcr1m6QGMnlx-Snj5WZ_S8z77Lf0f8AcFuVnw |
CitedBy_id | crossref_primary_10_3390_biomedicines8050119 crossref_primary_10_1042_BSR20204402 crossref_primary_10_1155_2021_6624702 crossref_primary_10_1016_j_bbcan_2021_188568 crossref_primary_10_1080_15384101_2022_2067438 crossref_primary_10_3389_fonc_2020_583217 crossref_primary_10_1016_j_heliyon_2023_e21549 crossref_primary_10_1007_s42764_022_00078_x crossref_primary_10_4103_jasmr_jasmr_34_22 crossref_primary_10_1007_s10528_021_10105_3 crossref_primary_10_62347_QWKZ3078 crossref_primary_10_1016_j_bbrc_2022_06_012 crossref_primary_10_1002_jbt_23392 crossref_primary_10_1159_000507828 crossref_primary_10_1371_journal_pone_0311130 crossref_primary_10_3389_fonc_2021_749142 crossref_primary_10_1096_fj_202400917R crossref_primary_10_4251_wjgo_v13_i12_1997 crossref_primary_10_1186_s12935_024_03256_x crossref_primary_10_2198_jelectroph_65_13 crossref_primary_10_1038_s41419_020_2528_7 crossref_primary_10_1007_s10495_022_01768_3 crossref_primary_10_1155_2022_1133332 crossref_primary_10_1007_s43032_024_01518_7 crossref_primary_10_1186_s13048_023_01170_w crossref_primary_10_2147_OTT_S267915 crossref_primary_10_1016_j_bbrc_2021_03_132 crossref_primary_10_1038_s41419_021_04123_7 crossref_primary_10_1155_ancp_8890200 crossref_primary_10_1096_fj_202001029R crossref_primary_10_1002_tox_23036 crossref_primary_10_3892_or_2021_8206 crossref_primary_10_1080_01635581_2022_2036351 crossref_primary_10_1016_j_jss_2020_11_052 crossref_primary_10_1016_j_molliq_2022_118928 crossref_primary_10_1097_CAD_0000000000001400 crossref_primary_10_1038_s41598_024_78022_0 crossref_primary_10_1089_cbr_2019_3512 crossref_primary_10_1002_mc_23305 crossref_primary_10_1002_1878_0261_13611 |
Cites_doi | 10.1042/BSR20190066 10.2147/CMAR.S163335 10.1038/onc.2012.214 10.1016/j.ajpath.2011.05.050 10.2337/diabetes.48.8.1593 10.1038/nrc3107 10.1038/nrc2867 10.1016/j.bbrc.2018.07.068 10.1089/dna.2019.4624 10.5607/en.2017.26.5.295 10.1038/nrc1997 10.1002/ijc.27711 10.1089/cbr.2017.2268 10.1039/C8MD00453F 10.1042/bj3290191 10.1002/jcb.28345 10.2337/diabetes.49.5.775 10.1038/nrc3932 10.1016/j.jmb.2010.07.051 10.1016/j.celrep.2018.01.058 10.1016/j.surg.2012.12.004 10.1038/s41417-018-0071-9 10.1074/jbc.270.48.28989 10.1158/0008-5472.CAN-12-0979 10.1016/j.cell.2009.01.046 10.18632/oncotarget.11252 10.1016/j.cmet.2006.02.002 10.1016/j.cmet.2006.01.012 10.1038/nrg2843 10.1074/jbc.M803508200 |
ContentType | Journal Article |
Copyright | 2019 The Author(s). 2019 The Author(s). 2019 |
Copyright_xml | – notice: 2019 The Author(s). – notice: 2019 The Author(s). 2019 |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.1042/BSR20190654 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1573-4935 |
ExternalDocumentID | PMC6732365 31409724 10_1042_BSR20190654 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .86 0R~ 23N 4.4 5GY 5RE 5VS 6J9 78A AAHRG AAYXX ABJNI ACGFS ACIWK ACPRK ADBBV ADIMF AEGXH AENEX AFBBN AFRAH AGIHE AHBYD ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR BGNMA CITATION CS3 DIK DL5 DU5 E3Z EBD EBS EJD EMOBN EPAXT F5P FRP GX1 H13 HYE HZ~ I09 IZQ KDC KQ8 LAK M48 M4Y MV1 NU0 O9- OK1 OVD QOK QOS R4E RHI RNS RPM RPO RPX RRX SBL SDH SDM SOJ SV3 TR2 TSK U2A VC2 ~EX AABGO NPM 7X8 5PM |
ID | FETCH-LOGICAL-c447t-d09dd2863d53eba1d59f5000684c5d4f4c648c0d2fe31400f812e6538e7db0253 |
IEDL.DBID | M48 |
ISSN | 0144-8463 1573-4935 |
IngestDate | Thu Aug 21 18:30:52 EDT 2025 Fri Jul 11 03:28:09 EDT 2025 Thu Apr 03 07:07:02 EDT 2025 Thu Apr 24 23:10:57 EDT 2025 Tue Jul 01 02:33:50 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | DNA synthesis PDK3 apoptosis gastric cancer cell cycle miR-497-5p |
Language | English |
License | 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c447t-d09dd2863d53eba1d59f5000684c5d4f4c648c0d2fe31400f812e6538e7db0253 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
ORCID | 0000-0003-0074-9073 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1042/BSR20190654 |
PMID | 31409724 |
PQID | 2273206068 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6732365 proquest_miscellaneous_2273206068 pubmed_primary_31409724 crossref_citationtrail_10_1042_BSR20190654 crossref_primary_10_1042_BSR20190654 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-09-30 |
PublicationDateYYYYMMDD | 2019-09-30 |
PublicationDate_xml | – month: 09 year: 2019 text: 2019-09-30 day: 30 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Bioscience reports |
PublicationTitleAlternate | Biosci Rep |
PublicationYear | 2019 |
Publisher | Portland Press Ltd |
Publisher_xml | – name: Portland Press Ltd |
References | Kim (2021111619493258500_B10) 2006; 3 Gudi (2021111619493258500_B28) 1995; 270 Lu (2021111619493258500_B12) 2011; 179 Papandreou (2021111619493258500_B11) 2006; 3 Wu (2021111619493258500_B5) 2018; 503 Holness (2021111619493258500_B30) 2000; 49 Guo (2021111619493258500_B22) 2013; 32 Wu (2021111619493258500_B29) 1999; 48 Chai (2021111619493258500_B6) 2018; 10 Chen (2021111619493258500_B8) 2016; 7 Calin (2021111619493258500_B17) 2006; 6 Bray (2021111619493258500_B1) 2013; 132 Krol (2021111619493258500_B2) 2010; 11 Lu (2021111619493258500_B9) 2008; 283 Yang (2021111619493258500_B15) 2018; 9 Xu (2021111619493258500_B25) 2019; 39 Bowker-Kinley (2021111619493258500_B27) 1998; 329 Zhou (2021111619493258500_B16) 2018; 22 Sun (2021111619493258500_B7) 2017; 32 Li (2021111619493258500_B24) 2019; 120 Cui (2021111619493258500_B13) 2018 Luo (2021111619493258500_B23) 2013; 153 Kluza (2021111619493258500_B31) 2012; 72 Ryan (2021111619493258500_B19) 2010; 10 Yu (2021111619493258500_B4) 2019; 17 Han (2021111619493258500_B14) 2017; 26 van Kouwenhove (2021111619493258500_B18) 2011; 11 Finnerty (2021111619493258500_B21) 2010; 402 Voinnet (2021111619493258500_B3) 2009; 136 Lin (2021111619493258500_B20) 2015; 15 Zhu (2021111619493258500_B26) 2019; 38 |
References_xml | – volume: 39 year: 2019 ident: 2021111619493258500_B25 article-title: MiR-876-5p regulates gastric cancer cell proliferation, apoptosis and migration through targeting WNT5A and MITF publication-title: Biosci. Rep. doi: 10.1042/BSR20190066 – volume: 10 start-page: 989 year: 2018 ident: 2021111619493258500_B6 article-title: MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells publication-title: Cancer Manage. Res. doi: 10.2147/CMAR.S163335 – volume: 32 start-page: 1910 year: 2013 ident: 2021111619493258500_B22 article-title: MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer publication-title: Oncogene doi: 10.1038/onc.2012.214 – volume: 17 start-page: 1330 year: 2019 ident: 2021111619493258500_B4 article-title: MicroRNA-490-3p regulates cell proliferation and apoptosis in gastric cancer via direct targeting of AKT1 publication-title: Exp. Ther. Med. – volume: 179 start-page: 1405 year: 2011 ident: 2021111619493258500_B12 article-title: Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2011.05.050 – volume: 48 start-page: 1593 year: 1999 ident: 2021111619493258500_B29 article-title: Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes publication-title: Diabetes doi: 10.2337/diabetes.48.8.1593 – volume: 11 start-page: 644 year: 2011 ident: 2021111619493258500_B18 article-title: MicroRNA regulation by RNA-binding proteins and its implications for cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3107 – volume: 10 start-page: 389 year: 2010 ident: 2021111619493258500_B19 article-title: Genetic variation in microRNA networks: the implications for cancer research publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2867 – volume: 503 start-page: 1491 year: 2018 ident: 2021111619493258500_B5 article-title: miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2018.07.068 – volume: 38 start-page: 849 year: 2019 ident: 2021111619493258500_B26 article-title: miR-383 inhibited the cell cycle progression of gastric cancer cells via targeting cyclin E2 publication-title: DNA Cell Biol. doi: 10.1089/dna.2019.4624 – volume: 26 start-page: 295 year: 2017 ident: 2021111619493258500_B14 article-title: Inhibition of HIF1alpha and PDK induces cell death of glioblastoma multiforme publication-title: Exp. Neurobiol. doi: 10.5607/en.2017.26.5.295 – volume: 6 start-page: 857 year: 2006 ident: 2021111619493258500_B17 article-title: MicroRNA signatures in human cancers publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1997 – volume: 132 start-page: 1133 year: 2013 ident: 2021111619493258500_B1 article-title: Global estimates of cancer prevalence for 27 sites in the adult population in 2008 publication-title: Int. J. Cancer doi: 10.1002/ijc.27711 – volume: 32 start-page: 371 year: 2017 ident: 2021111619493258500_B7 article-title: MicroRNA-497-5p suppresses tumor cell growth of osteosarcoma by targeting ADP ribosylation factor-like protein 2 publication-title: Cancer Biother. Radiopharm. doi: 10.1089/cbr.2017.2268 – volume: 9 start-page: 1843 year: 2018 ident: 2021111619493258500_B15 article-title: Discovery of potent pyruvate dehydrogenase kinase inhibitors and evaluation of their anti-lung cancer activity under hypoxia publication-title: MedChemComm doi: 10.1039/C8MD00453F – volume: 329 start-page: 191 year: 1998 ident: 2021111619493258500_B27 article-title: Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex publication-title: Biochem. J. doi: 10.1042/bj3290191 – volume: 120 start-page: 10587 year: 2019 ident: 2021111619493258500_B24 article-title: miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer publication-title: J. Cell. Biochem. doi: 10.1002/jcb.28345 – volume: 49 start-page: 775 year: 2000 ident: 2021111619493258500_B30 article-title: Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding publication-title: Diabetes doi: 10.2337/diabetes.49.5.775 – volume: 15 start-page: 321 year: 2015 ident: 2021111619493258500_B20 article-title: MicroRNA biogenesis pathways in cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3932 – volume: 402 start-page: 491 year: 2010 ident: 2021111619493258500_B21 article-title: The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2010.07.051 – volume: 22 start-page: 1810 year: 2018 ident: 2021111619493258500_B16 article-title: MicroRNA-223 suppresses the canonical NF-κB pathway in basal keratinocytes to dampen neutrophilic inflammation publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.01.058 – volume: 153 start-page: 836 year: 2013 ident: 2021111619493258500_B23 article-title: MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor publication-title: Surgery doi: 10.1016/j.surg.2012.12.004 – year: 2018 ident: 2021111619493258500_B13 article-title: Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia publication-title: Cancer Gene Ther. doi: 10.1038/s41417-018-0071-9 – volume: 270 start-page: 28989 year: 1995 ident: 2021111619493258500_B28 article-title: Diversity of the pyruvate dehydrogenase kinase gene family in humans publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.48.28989 – volume: 72 start-page: 5035 year: 2012 ident: 2021111619493258500_B31 article-title: Inactivation of the HIF-1alpha/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-0979 – volume: 136 start-page: 669 year: 2009 ident: 2021111619493258500_B3 article-title: Origin, biogenesis, and activity of plant microRNAs publication-title: Cell doi: 10.1016/j.cell.2009.01.046 – volume: 7 start-page: 58148 year: 2016 ident: 2021111619493258500_B8 article-title: miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma publication-title: Oncotarget doi: 10.18632/oncotarget.11252 – volume: 3 start-page: 177 year: 2006 ident: 2021111619493258500_B10 article-title: HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia publication-title: Cell Metab. doi: 10.1016/j.cmet.2006.02.002 – volume: 3 start-page: 187 year: 2006 ident: 2021111619493258500_B11 article-title: HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption publication-title: Cell Metab. doi: 10.1016/j.cmet.2006.01.012 – volume: 11 start-page: 597 year: 2010 ident: 2021111619493258500_B2 article-title: The widespread regulation of microRNA biogenesis, function and decay publication-title: Nat. Rev. Genet. doi: 10.1038/nrg2843 – volume: 283 start-page: 28106 year: 2008 ident: 2021111619493258500_B9 article-title: Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance publication-title: J. Biol. Chem. doi: 10.1074/jbc.M803508200 |
SSID | ssj0004934 |
Score | 2.4417045 |
Snippet | MicroRNA plays an important role in gastric cancer (GC) development, while the function of miR-497-5p in this disease remains unknown. In the present study, we... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
Title | miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31409724 https://www.proquest.com/docview/2273206068 https://pubmed.ncbi.nlm.nih.gov/PMC6732365 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dT9swED8B08Re0Ma-ygB5Ek-TvKX-7sOEGAyxIaaJrRpvkRPbbSQWShsk-O8512nVMh72FilnJ7pzcr_z-e4HsCcMOvHMSuq4NFQUjtOedCUtmLVGeKFCiAXOZz_USV98v5AXKzAj42wVOHk0tIt8Uv3x5cfb67t9_OA_pwwl-_Tl1zmLJdFKilV4gi5JRyqDM7HQNryX0stSc4rXsi3UezB42TX9gzcfHptc8EPHz2GjBZDkIFn8Baz4ehOeJkrJu01YP5wxuL2EP3-r88jtRuWIVPWwKqpmQgY2MnWUpIzmHpO4cU9Gkbon-LQYiK0dGWB03gxJy-JD0nlx9HLk59EpfwX946-_D09oS6RASyF0Q13Wc44ZxZ3kvrBdJ3shEiEoI0rpRBClEqbMHAueY8CVBfT6XuGv0GtXICjir2Gtvqr9WyCMWae7MmiunOgGYTACQhlpuXZam6wDH2Y6zMu2y3gku7jMp9luwfIFhXdgby48Ss01Hhd7PzNGjhqMirG1v7qZ5AzBF8swBjMdeJOMM5-IT1t5MRytl8w2F4iNtZfv1NVw2mBb4axcya3_eO47eBZfM50g2Ya1ZnzjdxCmNMUuAvRvp7vThXgPYuLlIQ |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=miR-497-5p+inhibits+gastric+cancer+cell+proliferation+and+growth+through+targeting+PDK3&rft.jtitle=Bioscience+reports&rft.au=Feng%2C+Lan&rft.au=Cheng%2C+Kai&rft.au=Zang%2C+Rongjia&rft.au=Wang%2C+Qingdong&rft.date=2019-09-30&rft.issn=1573-4935&rft.eissn=1573-4935&rft.volume=39&rft.issue=9&rft_id=info:doi/10.1042%2FBSR20190654&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0144-8463&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0144-8463&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0144-8463&client=summon |